Influence of an acidic beverage on the absorption of erlotinib
Phase of Trial: Phase IV
Latest Information Update: 10 May 2016
Price : $35 *
At a glance
- Drugs Erlotinib (Primary) ; Omeprazole
- Indications Lung cancer
- Focus Pharmacokinetics
- Acronyms COLA
- 08 Feb 2016 Results published in the Journal of Clinical Oncology
- 24 Dec 2015 Status changed from recruiting to completed as per Netherlands Trial Register record.
- 26 Jun 2015 Planned number of patients changed from 36 to 28 as per Netherlands Trial Register record.